Atara Biotherapeutics

📍 Thousand Oaks, United States🗓 Founded 2012👥 422 employees💰 Last funded Apr 2020
Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.  With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2012
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Atara Biotherapeutics?
Atara Biotherapeutics has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Atara Biotherapeutics last raise funding?
The most recent investment in Atara Biotherapeutics recorded on gritt.io was in April 2020.
When was Atara Biotherapeutics founded?
Atara Biotherapeutics was founded in 2012.
What industry is Atara Biotherapeutics in?
Atara Biotherapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Atara Biotherapeutics based?
Atara Biotherapeutics is headquartered in Thousand Oaks, United States.